|
|
|
|
| Advertisement |
White Paper: Orchestrated Customer Engagement - OCE is a new concept based on the principle of establishing greater trust between Life Sciences companies and their customers.
Sponsored by QuintilesIMS  Learn more
|
|
| Technology |
 |
|
Medical Game Changers Beckon |
Highlights of the top 10 transformative efforts the Cleveland Clinic thinks will show the greatest promise in impacting the practice of medicine in 2017
... /Read more/ |
|
|
| Viewpoint |
 |
|
Science: The Communal Language |
Despite industry's success in translating discovery research into products with proven clinical value, it continues to struggle in positioning medical research to the public as a distinctive force for good, writes William Looney
... /Read more/ |
|
|
|
| Calendar |
|
/ January 26–27, 2017: 12th Annual Biosimilars Summit / |
|
Alexandria, VA, USA |
|
/ February 8–9, 2017: Speaker Programs 2017 / |
|
Philadelphia, USA |
|
/ March 14–16, 2017: eyeforpharma Barcelona 2017 / |
|
Barcelona, Spain |
|
/ April 26-28, 2017: CBI's 14th Annual Pharmaceutical Compliance Congress / |
|
WASHINGTON, DC |
|
/ June 6–7, 2017: Pharmaceutical Compliance Congress Canada / |
|
Toronto, Canada |
|
|
|
| Industry update |
| //Lysogene (Paris, France) appointed David Schilansky to the Board of Directors as a non-executive, independent member.//AYOXXA Biosystems (Cologne, Germany) announced that Rodney Turner will continue to lead the company as CEO on a permanent basis, effective immediately.//Asceneuron (Lausanne, Switzerland) appointed J. Michael Ryan, M.D. as Chief Medical Officer. //Mission Therapeutics (Cambridge, UK) appointed Dr. Colin Goddard as non-executive Chairman, effective January 1st 2017.// |
|
|
|
|
| |
|
|
